| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.07. | Concord Medical Services Holdings Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| CONCORD MEDICAL SERVICES Aktie jetzt für 0€ handeln | |||||
| 13.05. | Concord Medical Services Holdings Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 29.04. | Concord Medical Services Holdings Ltd - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
| 15.04. | Concord Medical Services Holdings Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 26.09.25 | Concord Medical Services Holdings Limited: Concord Medical Reports Financial Results for the First Half of 2025 | 1.814 | PR Newswire | BEIJING, Sept. 26, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 79,96 | -0,32 % | Medtronic plc: Medtronic announces FDA clearance for LigaSure RAS Maryland instrument on the Hugo RAS system | Trusted vessel-sealing technology used in more than 45 million procedures worldwide is now cleared for robotic-assisted surgery in the U.S. GALWAY, Ireland, Sept. 16, 2026 /PRNewswire/... ► Artikel lesen | |
| FAMICORD | 3,000 | +1,69 % | Vita 34 erweitert die Stammzellvorsorge: Jetzt auch Plazentagewebe für die Zukunft sichern | Leipzig (ots) - Neben Nabelschnurblut und Nabelschnurgewebe kann ab sofort auch die Plazenta als wertvolle Stammzellquelle eingelagert werdenDie Geburt eines Kindes ist ein einzigartiger Moment. Sie... ► Artikel lesen | |
| DEXCOM | 78,20 | +0,51 % | Dexcom's CFO Jereme Sylvain To Take Addl. Role Of COO | WASHINGTON (dpa-AFX) - DexCom Inc. (DXCM), a medical device company, announced the promotion of Jereme Sylvain to the role of Chief Operating Officer in addition to his duties as Chief Financial... ► Artikel lesen | |
| CERENOME | 1,666 | -4,47 % | Cerenome, Inc.: Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division | HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), today announces the appointment of Samantha... ► Artikel lesen | |
| CARDINAL HEALTH | 196,40 | +0,15 % | Cardinal Health (NYSE:CAH) Vs Danaher Corporation (NYSE:DHR) - Here's The One Jim Cramer Said Did Better | ||
| DAVITA | 160,15 | +0,06 % | DaVita Community Care Report 2025: Empowering Teammates Through Career Development and Education | Paving Career Paths to Economic Mobility NORTHAMPTON, MA / ACCESS Newswire / September 14, 2026 / Sustainable career growth is about unlocking lasting economic mobility and new opportunities to learn... ► Artikel lesen | |
| MEDICLIN | 5,250 | -3,51 % | Mediclin: Indirekter Profiteur | Sondersituationen wie Übernahmen, Turnarounds oder Abfindungsspekulationen sind gerade in der Spezialwerteszene eine beliebte Anlagestrategie. So rückte im Herbst 2025 etwa der auf den Reha-Bereich... ► Artikel lesen | |
| DENTSPLY SIRONA | 8,420 | +1,32 % | DENTSPLY SIRONA Inc.: Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship | CHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, today announced an expansion of its... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| CENTENE | 56,36 | -0,56 % | Biotech Stocks At 52-Week Highs - Nutex Health +8%, Iovance Biotherapeutics +7%, AtriCure, Centene, Concentra Group | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on September 15, 2026, driven by the gain on certain clinical or financial results.Nutex Health Inc. (NUTX)Nutex Health... ► Artikel lesen | |
| BILLIONTOONE | 105,92 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| PROGYNY | 27,130 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| MIMEDX | 4,770 | 0,00 % | Cantor Fitzgerald reiterates Overweight on MiMedx stock at $8 | ||
| BRIGHTSPRING HEALTH SERVICES | 56,76 | 0,00 % | Here's Why You Should Add BrightSpring Stock to Your Portfolio Now | ||
| BETA BIONICS | 21,890 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock | IRVINE, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced the closing of its previously announced underwritten public offering of 7,652,175 shares of its... ► Artikel lesen |